Back

Mendelian randomization of the cardiovascular disease-related proteome identifies novel drug targets for gestational hypertension and preeclampsia

28 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Pregnancy: prediction and screening Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Art Schuermans

KU Leuven, Leuven (Belgium)

6 More presentations in this session

Presentation thumbnail
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Professor W. Justin Paul (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Association of adverse pregnancy outcomes with cardiovascular risk profile in later life - lessons learned from a large prospective population-based cohort-study
Ms E. Unger (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Implementing artificial intelligence-based cardio-obstetric screening in a diverse patient population: a prospective study
Assistant Professor D. Adedinsewo (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Reverse remodelling of right ventricle induced by pregnancy
Miss J. Machado Araujo (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Maternal hypertensive disorders of pregnancy and electrocardiographic findings in newborns
Mr E. Noerskov (Herlev, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Pregnancy: prediction and screening

The Event

Event poster

ESC Congress 2023

28 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation
thumbnail
Congress Presentation
Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.
thumbnail
Congress Presentation
Pregnancy associated hypertensive disorders and risk of cardiovascular disease: a mendelian randomisation study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources